DAVITA INC. — Director's Dealing 2021

Jun 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Miromatrix Medical Inc. (MIRO)
CIK: 0001527096
Period of Report: 2021-06-23

Reporting Person: Cheshire MD Holdings, LLC (10% Owner)
Reporting Person: DAVITA INC. (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-23	Warrants	$7.5	X	240000	Disposed	2021-06-28	Series C Preferred Stock (240000.0)	Direct
2021-06-23	Series C Preferred Stock	$	X	240000	Acquired		Common Stock (250000.0)	Direct
2021-06-23	Series C Preferred Stock	$	S	192000	Disposed		Common Stock (200000.0)	Direct
2021-06-23	Convertible Promissory Note	$7.5	X		Disposed	2021-09-06	Series C Preferred Stock (956887.0)	Direct
2021-06-23	Series C Preferred Stock	$	X	956887	Acquired		Common Stock (996757.0)	Direct

Footnotes

F1: As a result of DaVita Inc.'s ownership interest in Cheshire MD Holdings, LLC, DaVita Inc. may be deemed to have an indirect pecuniary interest in the shares held directly by Cheshire MD Holdings, LLC.

F2: Each share of Series C Preferred Stock has no expiration date and will automatically convert into shares of Common Stock upon the closing of the Issuer's Initial Public Offering at a rate determined by dividing $7.50 by $7.20.

F3: On June 23, 2021, Cheshire MD Holdings, LLC exercised the warrant to purchase 240,000 shares of the Issuer's Series C Preferred Stock for $7.50 a share. Pursuant to the terms of the warrant, Cheshire MD Holdings, LLC paid the exercise price on a cashless basis, resulting in the Issuer withholding 192,000 of the warrant shares to pay the exercise price and issuing to Cheshire MD Holdings, LLC the remaining 48,000 shares.